Disappointing Results for Tecovirimat Mpox Trial in the DRC Medical Countermeasures August 15, 2024 …
Lassa Fever Vaccine Study Supports Advancement to Phase I Trial Medical Countermeasures August 14, 2024 …
Are We There Yet? Agent Agnostic Metagenome Sequencing for Biothreat Detection Biodetection July 31, 2024 …
Thylacine Biotherapeutics Earns Top Honor in Medical Threat Reduction Challenge Medical Countermeasures July 9, 2024 …
CDC Health Alert: Increased Risk of Dengue Virus Infections in the United States Infectious Diseases June 25, 2024 …
Lacking Diagnostic Tools, Malaria Becomes Catch-All Diagnosis for Febrile Diseases in W. Africa Biodetection June 7, 2024 …
Pandemic Accord Negotiations Fall Short, Outcomes to Be Shared at World Health Assembly Health Security May 24, 2024 …
New Strategic Framework for Mpox Outbreak Control and Medical Countermeasures Infectious Diseases May 24, 2024 …
Haiti’s Collapsing Health System in a Time of Conflict and Cholera Infectious Diseases May 24, 2024 …
